ALT Graphic titled "VIP released an independent evidence review of respiratory virus immunizations." Includes logos of the Vaccine Integrity Project and CIDRAP. Text states, "Here's what the evidence found on the flu, COVID-19 and RSV immunizations." A rightward arrow is shown against a blue background with virus illustrations. CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image. Text reads, "The influenza review found: Among adults over 65, the flu vaccine increased protection against hospitalization by 31%.* Vaccine effectiveness was 80% against laboratory-confirmed influenza-associated deaths among infants and children aged 6 months to 17 years.** *according to an analysis of VISION Network data ** in a case-cohort analysis of national surveillance data over eight seasons (2016-2020, 2021-2025)" CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image. Text reads, "The COVID-19 review found: For adults over 65, vaccination cut the risk of COVID-related hospitalization by 53% in the 2025-26 respiratory virus season.  Maternal vaccination lowered the risk of emergency department and urgent care visits for pregnant women by 58% and to infants aged 0-2 months too with a vaccine effectiveness range of 50-54%. Vaccinated young children (9 months-4 years) saw a 76% reduction in COVID-related pediatric emergency department visits." CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image. Text reads, "The RSV review found: For adults over 60, studies showed significant protection against hospitalization, with vaccine effectiveness ranging from 69%-83% within the same season as vaccination. Vaccination during pregnancy reduced the risk of RSV among vaccinees by 82% and also reduced the risk of RSV-associated hospitalization among infants born subsequently. The infant monoclonal antibody immunization nirsevimab reduced the risk of RSV-related hospitalization by 64%-93% within 6-12 months." CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT President Donald Trump signs an executive order in the Oval Office.

ALT A multicolored illustration of the flu virus under a microscope

ALT Ebola disinfection

ALT Smiling older couple with their sleeves rolled up and bandaids on their upper arms

ALT Black mom holding her newborn in a hospital bed

ALT Illustration of US measles outbreak on back of young child

ALT Graphic w/ text: Center for Infectious Disease Research and Policy Endowed Program Fund School of Public Health Your support of this endowed fund sustains & provides a steady, predictable source of annual support to the Center for Infectious Disease Research & Policy (CIDRAP) as they remain a global leader in outreach, communication, and dissemination of authoritative information about infectious disease threats and to advance its most urgent work & meet new challenges as they arise.

ALT Woman in a jean jacket outdoors.

ALT Premature infant in an incubator, with focus on feet

ALT boy with measles

ALT polar bear

ALT Illustration of earth with green plants on one side and parched soil on the other

ALT A doctor checks his laptop as a mom holds her child

ALT Green broccoli sprouts on white background

ALT Geometric graphic featuring headshots of CIDRAP Director Dr. Osterholm and co-host Chris Dall. Text on graphic reads, "Osterholm Update" with CIDRAP logo in upper right corner.

ALT Tired nurse rests against a column in a busy hospital corridor